NousQ key facts
as of Oct 2026- Developer of tube insertion surgery technology intended to commercialise medical technology and devices for patients.
- NousQ is valued at approximately $21.8M as of Oct 2026 (last reported valuation).
- It has raised $9.6M.
- Notable investors include MedTech Innovator, WEVE Acceleration, National Research Foundation Singapore, Agency for Science, Be Health Ventures — 11 tracked in total.
- Status: Privately Held (backing).
NousQ's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch NousQ: the Monday email on marks, rounds and moves
NousQ funding rounds
No funding rounds for NousQ are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs NousQ
11+NousQ valuation
NousQ's last reported valuation was $21.8 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
NousQ investors
11 investors are on record for NousQ, including MedTech Innovator, WEVE Acceleration, National Research Foundation Singapore and Agency for Science.
About NousQ
Developer of tube insertion surgery technology intended to commercialise medical technology and devices for patients. The company's product offers a novel resolution for glue ears, uniquely programmed by a sensor and an automated algorithm adaptable for different eardrums, enabling clients to reduce cost, surgery risks, and glue ear-related complications.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2021
- Employees
- 11
- Website
- nousq.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.